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Summary: The authors have evaluated a new procedure for the estimation of pancreatic and salivary
isoamylase using a new selective inhibitor reagent (Enzamyl Isoamylase, Gödecke1), Germany; composition
covered by patent No. P 3404876.6).
Provided the conditions of the assay presented here are correctly selected, a Standard curve is not necessary
and the activities of both isoenzymes can be calculated by a simple* formula.
In view of its rapidity and precision, this new procedure appears to be useful äs a screening test. It correlates
closely with a reference electrophoretic method.
Bewertung eines neuen Verfahrens zur Messung der Isoamylasen durch selektive Hemmung
Zusammenfassung: Die Autoren haben ein neues Verfahren zur Bestimmung von Isoamylasen aus Pankreas
und Speichel überprüft, indem sie ein neues selektives Inhibitorreagenz (Enzamyl-Isoamylase, Gödecke1)
AG, Deutschland, Zusammensetzung gemäß Patent Nr. P 3404876.6) verwendeten.
Bei Wahl der richtigen Versuchsbedingungen kann auf eine Standardkurve verzichtet werden, und die
Berechnung der Aktivitäten der beiden Isoenzyme kann nach einer einfachen Formel erfolgen.
Wegen ihrer Schnelligkeit und Genauigkeit erscheint die neue Technik als Screeningtest geeignet. Sie korrelierte
sehr gut mit einer elektrophoretischen Referenzmethode.
Introduction he ,inearity of ±e residuai activity on
The present study deals with a new procedure for reference fluids (saliva, duodenal fluid) after inhibi-
measuring pancreatic isoamylase activity (Enzamyl tion under the suitable incubation conditions;
Isoamylase, Gödecke'), ̂  cov- ^^ on
ered by patent No. P 3404876.6). This procedure uses v ' *
a wheat germ selective inhibitor which is already (iv) to compare the results obtained on sera by this
knpwn (1—3), but obviates the need for a Standard new technique with those given by an electrophoretic
eurve by selecting an inhibitor concentration capable method.
of suppressing 50% of the panereatic isoenzyme ac-
tivity and J00% of the salivary isoenzyme activity. . ^nJ Material and Methods
The ahn of this investigation was: Samples
(i) to determine the ineubation conditions (time, tem, Fifteen duodenal fluid$ collected by duodenal mbing and forty
pefature, reagent mixture) required for the Operation sera were obtained from patients admitted to the wards. Saliva
of the calculation principle proposed by the manufac- was collected from fifteen healthy volunteers, Special care was
\ taken to avoid contamination of the duodenal fluid specimen
turer> collections by saliva: electrophoresis and blue starch staining
!) Now: Organon Teknika Medizinische Produkte GmbH, were used to assess the purity of each duodenal fluid and each
Freiburg im Breisgau. saliva.
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a-Amylase a c t i v i t y assay
Serum and duodenal fiuid α-amylase was measured on a Gem-
saec Centrifugal Analyzer (Electro Nucleonics Ine) at 30 °C by
the maltotetraose method (4): intraday precision for repeated
assay (n = 15), cocfilcient of Variation less than 2%; interday
precision at 2 levels of quality control material run in each
series (n = 20), coefficient of Variation less than 2.5%; activity
in serum sample stable for one week at room temperature and
at least 4 weeks at -20 °C; normal serum values up to 42 U/L
Electrophoresis of α-amylase isoenzymes
Electrophoresis was performed by a modificatioii of the method
of Takeuchi et al. (5); staining reagent was prepared according
to Davies (6).
Electrophoresis procedure
Cellulose acetate membranes were placed in 0.02 mol/l phos-
phate bufier (pH 7.40). After blotting, 3 μΐ of sample were
applied at the mid-point. Samples with high amylase activity
were diluted in the same buffer to give an activity afound 200
U/l. Electrophoresis was carried out at 4 °C in the same buffer
at 300 V for 2 hours.
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Fig. 1. Fraction of amylase inhibition (±SEM) s a function
of preincubation time at 30 °C in 5 saliva ( —o), 5
duodenal fluids (Δ — Δ) and 5 sera (D—g).
Slaining reagent preparation
Blue starch tablets (Phadebas Amylase tablets) were ground to
a fine powder in a mortar and mixed with 5 ml of 2% Agar-
Noble per tablet. The mixture was boiled for a further 30 min
and then kept at 42 °C.
Staining procedure
At the end of electrophoresis, membranes were blotted^ stained
by pouring the blue starch solution onto them and kept in an
incubator at 37 °C for one hour. After removal of the blue
starch gel, the cleaned and dried membranes were scanned in
a Beckman integrator (R112—115) using a 0.4 mm · 5 mm slit
beam (620 nm).
α-Amylase isoenzyme measurement by the selective
inhibition method
Inhibitor solution (Enzamyl Isoamylase, G decke1), Germany;
composition covered by patent No. P 3404876.6) and sample
were mixed in equal volumes. After incubation, the residual a-
amylase activity was measured and the results calculated s
follows:
l. pancreatic isoamylase activity (U/l) = residual activity · 4,
where 4 represents the sample/inhibitor predilution (· 2) and
the 50% inhibition of pancreatic isoenzyme;
2.0
2. salivary isoamylase activity (U/l)
creatic activity.
total activity — pan-
Results
Validation of experimental conditions and
calculation procedure
Figure l illustrates the relationship between inhibit-
ion and the preincubation time at 30 °C. For each of
the 3 fluids maximal inhibition was achieved or nearly
1.0
60
t i m i n ]
120
Fig. 2. Time course of a one-step procedure assay: (1) first
slope corresponding to the initial rate; (2) second slope
corresponding tp the activity remaining after inhibition.
achieved at a preincubation time of 60 min onwards:
more than 90% for saliva, aro nd 45-50% for duo-
denal fluid and 60% for serum.
The temperature of preincubation does not influence
the res lt; no difference was f und between experi-
ments performed at 25 °C and 37 °C; however results
obtained at 25 °C were more scattered owing to the
low residual activities (approaching the detection li-
mit) recorded at that temperature.
Figure 2 presents the results of a continuous assay
where 50 μΐ of Inhibitor, 50 μΐ of serum and l ml
reagent were mixed at once aq^ the kinetics recorded
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on a spectrophotometer Beckman (model 25). In 3
sera, total activity was estimated from the extrapol-
ation of the initial rate and residual activity after
Inhibition from the second slope. These res lts were
compared with those obtained with the same sera by
a two-step procedure. This comparison reveals that
neither total activity nor maximal Inhibition could be
correctly estimated by the one-step procedure and
that their reliable determinations require preliminary
measurement of total activity and a one hour preincu-
bation with the inhibitor.
Figure 3 shows the residual activities recorded when
a same voluine (50 μΐ) of sample (duodenal fluid or
saliva) was preincubated with increasing volumes of
the inhibiting solution. This graph reveals that a 50%
of pancreatic amylase activity was only obtained for
a l/l (v : v) sample-inhibitor ratio.
Another set of 3 experiments was devised to validate
the calculation procedure. One aliquot of duodenal
juice and a second one preincubated for l hour with
the Inhibition solution (1:1) were submitted to elec-
trophoresis; after staining, the electrophoretic spots
were scanned in a direction perpendicular to the line
of migration (fig. 4). The res lts show that the ratio
between the areas of initial and residual activities
ranged from 77-23% to 83-17% and thus came
close to the 80—20% ratio expected from the theoret-
ical calculation.
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Fig. 3. Evolution of amylase Inhibition in salivary (o —o) and
duodenal (Δ - Δ) fluid (50 μΐ of each) s a function of








Fig. 4. Experimental design to validate the 50% Inhibition of
pancreatic isoamylase by an electrophoretic method
(S = saliva; P = duodenal fluid; P Hr I = mixture of
duodenal fluid and inhibiting solution; A = appli-
cation).
Linearity of reaction
Total and residual α-amylase activities measured in
saliva and duodenal fluid under the preincubation
conditions selected are plotted in figure 5 against the
corresponding dilutions. The assay is linear up to 350
U/l for total activity and at least up to 200 U/l for
residual activity after Inhibition. It must be noticed
that in the case of salivary amylase, Inhibition was
never complete: above 1.00 U/l total activity, a 5%












Fig. 5. Evaluation of total and residual α-amylase activities in
saliva and duodenal fluid s a function of sample dilu-
tion (S = saliva; P = duodenal fluid; S + I and P +
I = mixture Of saliva or duodenal fluid and inhibiting
solution).
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Between assays precision
Twenty sera were repeatedly estimated in 6 assays:
the coefficients of Variation never exceeded 2% for
total amylase activities and increased up to 3.6% for
residual activities above 10 U/l and to 12.5% for still
lower values approaching detection limit. It must
however be noted that even in these last cases, the
Standard deviation of between assays precision re-
mained äs low äs 0.5 U/l.
Comparison to a reference method
In figure 6 the values obtained from 22 sera by the
selective Inhibition technique (ordinates) are plotted
against the corresponding values given by the elec-
trophoretic method (abscissa). The formula of the
regression line was y = 1.02 + 2 and its slope was
not significantly different from the identity line =
1.00 (t = 0.6338, p > 0.50); moreover the Standard
deviation from regression was equal to 10 U/l (/. e. a
CV of 12% for mean value). These features empha-







Fig. 6. Correlation between the electrophoretic method arid the
selective Inhibition method for measuring pancreatic
isoamylase activity (y = 1.02 + 2; r = 0.9923; n =
22; p = 0.001).
Discussion
The present evaluation based upon the use of refer-
ence fluids reveals that the type of calculation for-
warded by the manufacturer to estimate the Contents
in pancreatic and salivary amylase activities of biolog-
ical fluids is valid providing folldwing conditions are
fulfilled:
— the use of a two-step procedure with determi-
nation of total activity in one aliquot, and of
residual activity after selective Inhibition in a dif-
ferent aliquot.
— a l/l (v : v) ratio between sample and inhibiting
mixture;
— a one hour incubation of sample and inhibiting
mixture before measuring residual activity;
— a residual activity after Inhibition greater than
5% of total activity.
The last condition is based on the fact that Inhibition
of salivary amylase never exceeded 95% of total
activity. Application of the calculation formula for
total activity concentfations greater than 300 U/l
would thus provide a value above 30 U/l for the pan-
creatic component even in the case of a hyperamyla-
saemia of pure salivary origin.
Applied to sera täken at random, this technique has
provided results superimposable on those obtained
with an electrophoretic reference method.
The repeatablility of the technique is quite satisfac-
tory except for very low residual values that can only
be observed with fluids displaying a poor content of
pancreatic amylase and a high content of the salivary
isoenzyme. However, it must be noted that this assay
is primarily designed to estimate with precision the
pancreatic component in hyperamylasaemia of
doubtful aetiology, a Situation that is often encqun-
tered when amylasaemia rises two- or three-fold
above the upper normal limit (7, 8). In this Situation,
the new assay may be suggested äs a suitable screen-
ing test, in view öf its linearity, its repeatablility and
its simplicity linked the fact that ä Standard curve is
not needed. Nevertheless, a careful evaluation of this
assay in pancreatitis attacks is still to be made, in
order to assign its place among the other diagnostic
tests. Indeed it must be remembefed that simultane-
ous determination of amylase and pancreatic lipase
in plasma by rapid and accurate methods has already
achieved a very high level of confideüce for the detec-
tion of acute or relapsing pancreatic disorders (7* 8).
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